Log in
Enquire now
‌

US Patent 11912782 BCMA monoclonal antibody-drug conjugate

Patent 11912782 was granted and assigned to MedImmune, LLC on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
MedImmune, LLC
MedImmune, LLC
0
Date Filed
March 29, 2021
0
Date of Patent
February 27, 2024
0
Patent Applicant
MedImmune, LLC
MedImmune, LLC
0
Patent Application Number
17215479
0
Patent Citations
‌
US Patent 10988546 BCMA monoclonal antibody-drug conjugate
0
Patent Inventor Names
Xiaodong Xiao
0
David Tice
0
Krista Kinneer
0
Reena Varkey
0
Elaine M. Hurt
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11912782
0
Patent Primary Examiner
‌
Lynn A Bristol
0
CPC Code
‌
A61K 2039/505
0
‌
A61K 47/6849
0
‌
A61K 47/6803
0
‌
A61K 47/6867
0

Find more entities like US Patent 11912782 BCMA monoclonal antibody-drug conjugate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.